Important note

This AI stock analysis for Teladoc Health is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Teladoc Health - AI Stock Analysis

Analysis generated May 7, 2025

Teladoc Health, Inc. (NYSE: TDOC) is a leader in the telehealth sector, providing virtual healthcare services globally. The company offers a range of services, including mental health, dermatology, and chronic condition management. Teladoc's platform connects patients with medical professionals through phone, video, and mobile app consultations, allowing for accessible, on-demand healthcare solutions.

Fundamental Analysis

Teladoc Health's recent financial performance raises some red flags. The company's revenue for the last quarter was reported at $629 million. This marks a decrease of 1.74% compared to the previous quarter and a 2.59% decline year-over-year. This stagnation indicates potential issues in market penetration or customer retention.

More alarming is the net income for the last quarter, which stood at $93 million. This figure signifies a sharp decline of 92.14% from the prior quarter and a 13.58% drop from the same quarter last year. This steep reduction in net income points to underlying operational or market challenges that the company needs to address.

Furthermore, the EBITDA for the last quarter was $121 million, revealing an eye-popping decrease of 339.56% from the previous quarter and a staggering drop of 547.45% compared to the same quarter last year. These figures underline a severe profitability issue that could undermine long-term sustainability.

Adding to these concerns, a few company insiders have sold their stock in recent months. Insider selling can often serve as a bearish signal, suggesting that those closest to the company might have a lack of confidence in its near-term prospects.

Technical Analysis

Teladoc Health's current stock price stands at $6.86, a 5.12% decrease from last month and a striking 43.77% decrease from the same time last year—indicating a troubling bearish trend. The current Simple Moving Average (SMA10) is 7.06, down from the previous SMA10 of 7.10, which suggests continuing downward momentum in the stock price.

The Relative Strength Index (RSI) is 44.3, positioning the stock in a neutral state; however, the movement of price indicators and overall downward trend signifies potential short-term weakness.

Alternative Data Analysis

In terms of job postings and employee sentiment, Teladoc Health has 62 open positions, a decrease of 48% over the last couple of months. This drop may indicate cost-cutting measures but is concerning for a company in a growth industry. Additionally, only 33% of employees hold a positive business outlook, down 18% in recent months, suggesting growing internal pessimism.

Customer acquisition metrics are equally concerning. The company's website attracts an estimated 810,000 visitors, which is down by 15% over the last couple of months. Similarly, mobile app downloads stand at an estimated 1,100 per day, a significant 67% drop, which could indicate a serious decline in consumer interest.

On the engagement front, Teladoc Health has 13,000 followers on Instagram, a 6% increase, and 18,000 followers on Twitter, with stable numbers. However, social media engagement seems meager, and the modest increase on Instagram may not compensate for the other troubling trends.

Lastly, using AltIndex's AI score, which predicts stock movements based on a mix of fundamental, technical, and alternative data, Teladoc Health has an AI score of 26, signaling a strong sell recommendation.

Conclusion

In summary, Teladoc Health is facing a confluence of challenges. The company's fundamental metrics show declining revenues, net income, and EBITDA, which undermine financial stability. Technical indicators point to a bearish trend, while alternative data suggests weakening employee sentiment, reducing job postings, and declining customer acquisition and engagement metrics.

While the increase in social media followers is a positive sign, it pales in comparison to the broader concerns. Given these diverse sets of data, the recommendation leans towards caution. Investors might consider reassessing their portfolios and approach Teladoc Health with heightened scrutiny and a potential negative bias.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.